← 產業報告目錄

Rapid Microbiology Testing Market by Product (Instruments (Mass Spectrometers), Consumables), Method (Nucleic Acid-based), Application (Industrial Testing (Food & Beverage), Clinical Diagnosis), End User (Hospitals), & Region - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-06-16頁數 436報告編號 MD6602

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The market for rapid microbiology testing is projected to grow from USD 5.69 billion in 2026 to USD 9.00 billion by 2031, reflecting a CAGR of 9.6%. Market growth is supported by rising pharmaceutical and biopharmaceutical production, stringent sterility and contamination control requirements, and expanding use of molecular diagnostics and automated microbiology systems. Additionally, advancements in Polymerase Chain Reaction (PCR), mass spectrometry, and rapid microbial identification technologies are improving laboratory efficiency and supporting broader adoption globally. "By product, reagents & Kits segment to showcase highest CAGR during forecast period” The growth of the reagents & kits segment is primarily driven by the recurring demand for culture media, assay kits, primers, probes, stains, buffers, and antimicrobial susceptibility testing reagents used in rapid microbiology workflows. Rising incidences of infectious diseases and increasing emphasis on sterility assurance and contamination control are accelerating testing volumes across hospitals, pharmaceutical & biotechnology companies, and food testing laboratories. Additionally, expanding adoption of molecular microbiology techniques, automated testing platforms, and rapid PCR-based assays is expected to further drive demand for reagents & kits throughout the forecast period. “By method, growth-based segment to hold the largest share of rapid microbiology testing market in 2026" A growth-based rapid microbiology testing method is likely to dominate the market in 2026 due to its extensive use in pharmaceutical sterility testing, environmental monitoring, food safety testing, and clinical microbiology workflows. Growth-based rapid microbiology methods are widely adopted because they provide reliable detection of viable microorganisms while supporting regulatory compliance and quality assurance requirements. The increasing adoption of automated microbial detection systems, rising demand for faster contamination identification, and growing pharmaceutical and biopharmaceutical manufacturing activities are further driving segment growth. Additionally, the need for rapid product release and improved laboratory efficiency continues to support demand for growth-based testing methods. "Asia Pacific to register fastest growth rate in rapid microbiology testing market during forecast period" The region is witnessing significant growth due to expanding healthcare infrastructure, increasing healthcare expenditure, and rapid modernization of hospitals, diagnostic laboratories, and pharmaceutical manufacturing facilities. Rising prevalence of infectious diseases and growing awareness regarding contamination control and patient safety are increasing the demand for rapid microbial diagnostics across the region. Additionally, increasing investments in biotechnology research, biopharmaceutical production, and laboratory automation are further supporting market expansion. The growing adoption of molecular diagnostics, rapid PCR systems, and automated microbial identification technologies is also contributing to market growth. Major countries driving regional expansion include China, India, Japan, and South Korea. Breakdown of primary participants in the rapid microbiology testing market is as follows: • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%) • By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%) • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%) The key players in the rapid microbiology testing market are bioMérieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Bruker Corporation (US), QuidelOrtho Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Charles River Laboratories International, Inc. (US), Neogen Corporation (US), Bio-Rad Laboratories, Inc. (US), Shimadzu Corporation (Japan), and Rapid Micro Biosystems, Inc. (US). Research Coverage: This research report categorizes the rapid microbiology testing market by product (consumables, instruments, reagents & kits), method (growth-based, cellular component-based, nucleic acid-based, viability-based, and other methods) application (industrial testing, clinical disease diagnosis, and research applications), end user (hospitals, clinical laboratories, & ASCs; pharmaceutical & biotechnology companies; food & beverage companies; environmental & water testing laboratories; and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the rapid microbiology testing market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and key strategies, such as partnerships, collaborations, expansions, agreements, product launches, and recent developments in the rapid microbiology testing market. This report covers the competitive analysis of upcoming startups in the rapid microbiology testing ecosystem. Reasons to Buy This Report: The report will help leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall rapid microbiology testing market and its subsegments. This report will help stakeholders understand the competitive landscape and gain deeper insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (increasing burden of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases; technological advancements in automated microbiology and MALDI-TOF platforms; growing food safety concerns and rising incidence of foodborne illnesses; increasing R&D activities in microbiology and infectious disease), restraints (high capital investments and low cost-benefit ratio, unfavorable regulatory and reimbursement scenario, shortage of skilled personnel), opportunities (growing demand for rapid microbiology testing in emerging economies, expansion of rapid microbial testing applications), and challenges (operational barriers, high investment for automated microbial identification systems) • Product development/innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the rapid microbiology testing market. • Market development: Comprehensive information about lucrative markets; the report analyzes the rapid microbiology testing market across varied regions. • Market diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the rapid microbiology testing market. • Competitive assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like bioMérieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific, Inc. (US).
目錄 Table of Contents
1 INTRODUCTION 39 1.1 STUDY OBJECTIVES 39 1.2 MARKET DEFINITION 39 1.3 STUDY SCOPE 40 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 40 1.3.2 INCLUSIONS AND EXCLUSIONS 41 1.3.3 YEARS CONSIDERED 42 1.3.4 CURRENCY CONSIDERED 42 1.4 STAKEHOLDERS 42 1.5 SUMMARY OF CHANGES 43 2 EXECUTIVE SUMMARY 44 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 44 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 45 2.3 DISRUPTIVE TRENDS SHAPING MARKET 46 2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 47 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 48 3 PREMIUM INSIGHTS 49 3.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW 49 3.2 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2026 VS. 2031 50 3.3 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2026 VS. 2031 50 3.4 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2026 VS. 2031 51 3.5 RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2026 VS. 2031 51 3.6 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52 4 MARKET OVERVIEW 53 4.1 INTRODUCTION 53 4.2 MARKET DYNAMICS 53 4.2.1 DRIVERS 54 4.2.1.1 Increasing burden of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases 54 4.2.1.2 Technological advancements in automated microbiology and MALDI-TOF platforms 55 4.2.1.3 Growing food safety concerns and rising incidence of foodborne illnesses 56 4.2.1.4 Increasing R&D in microbiology and infectious diseases 57   4.2.2 RESTRAINTS 58 4.2.2.1 High capital investments and low cost-benefit ratio 58 4.2.2.2 Unfavorable regulatory and reimbursement scenario 58 4.2.2.3 Shortage of skilled personnel 58 4.2.3 OPPORTUNITIES 59 4.2.3.1 Growing demand for rapid microbiology testing in emerging economies 59 4.2.3.2 Expansion of rapid microbial testing applications 59 4.2.4 CHALLENGES 60 4.2.4.1 Operational barriers 60 4.2.4.2 High investment for automated microbial identification systems 60 4.3 UNMET NEEDS AND WHITE SPACES 61 4.3.1 UNMET NEEDS IN RAPID MICROBIOLOGY TESTING MARKET 61 4.3.2 WHITE SPACE OPPORTUNITIES 62 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 63 4.4.1 INTERCONNECTED MARKETS 63 4.4.2 CROSS-SECTOR OPPORTUNITIES 64 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 65 4.5.1 KEY MOVES AND STRATEGIC FOCUS 65 5 INDUSTRY TRENDS 66 5.1 PORTER’S FIVE FORCES ANALYSIS 66 5.1.1 BARGAINING POWER OF SUPPLIERS 67 5.1.2 BARGAINING POWER OF BUYERS 67 5.1.3 THREAT OF NEW ENTRANTS 67 5.1.4 THREAT OF SUBSTITUTES 67 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 67 5.2 MACROECONOMIC INDICATORS 68 5.2.1 INTRODUCTION 68 5.2.2 GDP TRENDS AND FORECAST 68 5.3 SUPPLY CHAIN ANALYSIS 71 5.4 VALUE CHAIN ANALYSIS 72 5.5 ECOSYSTEM ANALYSIS 74 5.5.1 RAPID MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 75 5.6 PRICING ANALYSIS 75 5.6.1 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2024–2026 76 5.6.2 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024–2026 76 5.7 TRADE ANALYSIS 77 5.7.1 IMPORT SCENARIO (HS CODE 3822) 78 5.7.2 EXPORT SCENARIO (HS CODE 3822) 78 5.8 KEY CONFERENCES & EVENTS, 2026–2027 79 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79 5.10 INVESTMENT & FUNDING SCENARIO 80 5.11 CASE STUDY ANALYSIS 81 5.11.1 YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS 81 5.11.2 RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS 81 5.11.3 RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION 82 5.12 IMPACT OF US TARIFFS—RAPID MICROBIOLOGY TESTING MARKET 82 5.12.1 INTRODUCTION 82 5.12.2 KEY TARIFF RATES 83 5.12.3 PRICE IMPACT ANALYSIS 83 5.12.4 IMPACT ON COUNTRIES/REGIONS 84 5.12.4.1 North America 84 5.12.4.2 Europe 84 5.12.4.3 Asia Pacific 84 5.12.5 IMPACT ON END-USE INDUSTRIES 84 5.12.5.1 Hospitals, Clinical Laboratories, and ASCs 84 5.12.5.2 Pharmaceutical & Biotechnology Companies 85 5.12.5.3 Food & Beverage Companies 85 5.12.5.4 Environmental & Water Testing Laboratories 85 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 86 6.1 KEY EMERGING TECHNOLOGIES 86 6.1.1 AUTOMATED MULTIPLEX PCR SYSTEMS 86 6.1.2 BIOSENSORS 86 6.2 COMPLEMENTARY TECHNOLOGIES 86 6.2.1 OPTICAL IMMUNOSENSORS 86 6.2.2 ELECTROCHEMICAL IMMUNOSENSORS 87 6.3 ADJACENT TECHNOLOGIES 87 6.3.1 DIGITAL PCR (DPCR) 87 6.4 TECHNOLOGY/PRODUCT ROADMAP 87 6.5 PATENT ANALYSIS 88 6.5.1 LIST OF MAJOR PATENTS 89 6.6 FUTURE APPLICATIONS 90 6.7 IMPACT OF AI/GENERATIVE AI ON RAPID MICROBIOLOGY TESTING MARKET 90 6.7.1 INTRODUCTION 90 6.7.2 TOP USE CASES AND MARKET POTENTIAL 91 6.7.3 KEY COMPANIES IMPLEMENTING AI 91 6.7.4 FUTURE OF AI 92 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 93 7.1 REGIONAL REGULATIONS AND COMPLIANCE 93 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 7.1.2 INDUSTRY STANDARDS 95 7.2 SUSTAINABILITY INITIATIVES 96 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN RAPID MICROBIOLOGY TESTING 96 7.2.1.1 Eco-friendly Initiatives 97 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 98 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 99 8.1 DECISION-MAKING PROCESS 99 8.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 99 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 99 8.2.2 BUYING CRITERIA 100 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 101 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 102 8.5 MARKET PROFITABILITY 103 8.5.1 REVENUE POTENTIAL 103 8.5.2 COST DYNAMICS 104 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 104 9 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT 106 9.1 INTRODUCTION 107 9.2 INSTRUMENTS 107 9.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS 112 9.2.1.1 Ease of use compared to conventional identification processes to support market growth 112 9.2.2 MASS SPECTROMETERS 115 9.2.2.1 Rapid results associated with mass spectrometry methods to boost adoption 115 9.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS 118 9.2.3.1 Unwanted detection of non-microbial ATP to limit market adoption 118 9.2.4 PCR SYSTEMS 121 9.2.4.1 Growing use of standard, real-time, and qPCR for rapid microbial testing to support growth 121 9.2.5 CYTOMETERS 124 9.2.5.1 Ability to detect viable organisms to favor market growth 124 9.2.6 ACTIVE AIR SAMPLERS 127 9.2.6.1 Convenience and ease of use to drive demand for active air samplers 127 9.2.7 OTHER INSTRUMENTS 130 9.3 REAGENTS & KITS 133 9.3.1 STERILITY TESTING REAGENTS & KITS 136 9.3.1.1 Increasing adoption of BET assays to propel market growth 136 9.3.2 OTHER REAGENTS & KITS 139 9.4 CONSUMABLES 142 9.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH 142 10 RAPID MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS 146 10.1 INTRODUCTION 146 10.2 GLOBAL: VOLUME OF MALDI-TOF MS MICROBIAL IDENTIFICATION SYSTEM INSTALLED BASE 146 11 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD 147 11.1 INTRODUCTION 148 11.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING 149 11.2.1 RISING DEMAND FOR GROWTH-BASED TESTING TO DRIVE MARKET 149 11.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING 152 11.3.1 HIGH SENSITIVITY, ACCURACY, AND SPECIFICITY OF CELLULAR COMPONENT-BASED METHODS TO BOOST MARKET 152 11.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING 155 11.4.1 HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH 155 11.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING 158 11.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND 158 11.6 OTHER METHODS 161 12 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION 165 12.1 INTRODUCTION 166 12.2 INDUSTRIAL TESTING 166 12.2.1 FOOD & BEVERAGE TESTING 170 12.2.1.1 Stringent quality control and quality assurance processes to drive market growth 170 12.2.2 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING 173 12.2.2.1 Improved regulatory scenario for drug development to support market growth 173 12.2.3 ENVIRONMENTAL TESTING 177 12.2.3.1 Growing focus on environmental monitoring to boost segmental growth 177 12.2.4 COSMETIC & PERSONAL CARE PRODUCTS TESTING 180 12.2.4.1 Growing use of rapid microbiology testing to determine the presence of microbes favors market growth 180 12.2.5 OTHER INDUSTRIAL TESTING APPLICATIONS 184   12.3 CLINICAL DISEASE DIAGNOSIS 187 12.3.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HEALTHCARE-ASSOCIATED INFECTIONS TO PROPEL MARKET GROWTH 187 12.4 RESEARCH 191 12.4.1 INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH 191 13 RAPID MICROBIOLOGY TESTING MARKET, BY END USER 195 13.1 INTRODUCTION 196 13.2 HOSPITALS, CLINICAL LABORATORIES, AND ASCS 196 13.2.1 INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 196 13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 200 13.3.1 STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND 200 13.4 FOOD & BEVERAGE COMPANIES 203 13.4.1 STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH 203 13.5 ENVIRONMENTAL & WATER TESTING LABORATORIES 206 13.5.1 GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND 206 13.6 OTHER END USERS 210 14 RAPID MICROBIOLOGY TESTING MARKET, BY REGION 214 14.1 INTRODUCTION 215 14.2 NORTH AMERICA 215 14.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 216 14.2.2 US 221 14.2.2.1 Increasing prevalence of infectious diseases to drive market 221 14.2.3 CANADA 225 14.2.3.1 Supportive government initiatives and increased research funding to boost market 225 14.3 EUROPE 230 14.3.1 EUROPE: MACROECONOMIC OUTLOOK 230 14.3.2 GERMANY 234 14.3.2.1 Favorable government policies to propel market 234 14.3.3 FRANCE 239 14.3.3.1 Favorable healthcare reforms and investments in diagnostic infrastructure to drive market 239 14.3.4 UK 242 14.3.4.1 Emphasis on food contamination monitoring and hygiene controls to drive market 242 14.3.5 ITALY 246 14.3.5.1 Improved healthcare services and better disease surveillance to support market growth 246 14.3.6 SPAIN 251 14.3.6.1 Water monitoring mandate to boost market growth 251 14.3.7 RUSSIA 255 14.3.7.1 Strengthening water quality surveillance and outbreak response drives adoption in Russia 255 14.3.8 REST OF EUROPE 259 14.4 ASIA PACIFIC 263 14.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 263 14.4.2 CHINA 267 14.4.2.1 Increasing government focus on disease prevention to drive market 267 14.4.3 JAPAN 272 14.4.3.1 Stringent safety laws and foodborne outbreaks to fuel uptake 272 14.4.4 INDIA 276 14.4.4.1 High target patient population to boost demand 276 14.4.5 SOUTH KOREA 280 14.4.5.1 Favorable government initiatives for medical tourism to support market growth 280 14.4.6 AUSTRALIA 284 14.4.6.1 Favorable healthcare automation techniques to support market growth 284 14.4.7 REST OF ASIA PACIFIC 288 14.5 LATIN AMERICA 291 14.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 292 14.5.2 BRAZIL 297 14.5.2.1 Improving healthcare infrastructure and stringent regulations to fuel market 297 14.5.3 MEXICO 301 14.5.3.1 Increasing prevalence of HIV to drive market 301 14.5.4 REST OF LATIN AMERICA 304 14.6 MIDDLE EAST & AFRICA 308 14.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 310 14.6.2 SAUDI ARABIA 314 14.6.2.1 Increasing focus on healthcare automation to drive market 314 14.6.3 UNITED ARAB EMIRATES (UAE) 318 14.6.3.1 Improvements in healthcare infrastructure to support market growth 318 14.6.4 REST OF MIDDLE EAST & AFRICA 322 15 COMPETITIVE LANDSCAPE 326 15.1 INTRODUCTION 326 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 326 15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET 326 15.3 REVENUE ANALYSIS, 2023–2025 328   15.4 MARKET SHARE ANALYSIS, 2025 328 15.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025 329 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 331 15.5.1 STARS 331 15.5.2 EMERGING LEADERS 331 15.5.3 PERVASIVE PLAYERS 331 15.5.4 PARTICIPANTS 331 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 333 15.5.5.1 Company footprint 333 15.5.5.2 Region footprint 334 15.5.5.3 Product footprint 335 15.5.5.4 Application footprint 335 15.5.5.5 End-user footprint 336 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 336 15.6.1 PROGRESSIVE COMPANIES 336 15.6.2 RESPONSIVE COMPANIES 336 15.6.3 DYNAMIC COMPANIES 337 15.6.4 STARTING BLOCKS 337 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 338 15.6.5.1 Detailed list of key startups/SMEs 338 15.6.5.2 Competitive benchmarking of startups/SMEs 339 15.7 COMPANY VALUATION & FINANCIAL METRICS 340 15.7.1 FINANCIAL METRICS 340 15.7.2 COMPANY VALUATION 340 15.8 BRAND/PRODUCT COMPARISON 341 15.9 COMPETITIVE SCENARIO 341 15.9.1 PRODUCT LAUNCHES & APPROVALS 341 15.9.2 DEALS 342 15.9.3 EXPANSIONS 343 16 COMPANY PROFILES 344 16.1 KEY PLAYERS 344 16.1.1 BIOMÉRIEUX 344 16.1.1.1 Business overview 344 16.1.1.2 Products offered 346 16.1.1.3 Recent developments 348 16.1.1.3.1 Product launches & approvals 348 16.1.1.3.2 Deals 349 16.1.1.3.3 Other developments 350 16.1.1.4 MnM view 350 16.1.1.4.1 Right to win 350   16.1.1.4.2 Strategic choices 351 16.1.1.4.3 Weaknesses & competitive threats 351 16.1.2 WATERS CORPORATION 352 16.1.2.1 Business overview 352 16.1.2.2 Products offered 354 16.1.2.3 Recent developments 355 16.1.2.3.1 Product approvals 355 16.1.2.3.2 Deals 355 16.1.2.4 MnM view 356 16.1.2.4.1 Right to win 356 16.1.2.4.2 Strategic choices 356 16.1.2.4.3 Weaknesses & competitive threats 356 16.1.3 DANAHER CORPORATION 357 16.1.3.1 Business overview 357 16.1.3.2 Products offered 358 16.1.3.3 Recent developments 360 16.1.3.3.1 Product approvals 360 16.1.3.3.2 Deals 360 16.1.3.4 MnM view 361 16.1.3.4.1 Right to win 361 16.1.3.4.2 Strategic choices 361 16.1.3.4.3 Weaknesses & competitive threats 361 16.1.4 ABBOTT LABORATORIES 362 16.1.4.1 Business overview 362 16.1.4.2 Products offered 363 16.1.4.3 Recent developments 365 16.1.4.3.1 Product approvals 365 16.1.4.4 MnM view 365 16.1.4.4.1 Right to win 365 16.1.4.4.2 Strategic choices 365 16.1.4.4.3 Weaknesses & competitive threats 365 16.1.5 THERMO FISHER SCIENTIFIC INC. 366 16.1.5.1 Business overview 366 16.1.5.2 Products offered 367 16.1.5.3 Recent developments 369 16.1.5.3.1 Product launches 369 16.1.5.3.2 Deals 369 16.1.5.4 MnM view 370 16.1.5.4.1 Right to win 370 16.1.5.4.2 Strategic choices 370 16.1.5.4.3 Weaknesses & competitive threats 370   16.1.6 BRUKER CORPORATION 371 16.1.6.1 Business overview 371 16.1.6.2 Products offered 373 16.1.6.3 Recent developments 374 16.1.6.3.1 Product launches & approvals 374 16.1.6.3.2 Deals 374 16.1.7 QUIDELORTHO CORPORATION 375 16.1.7.1 Business overview 375 16.1.7.2 Products offered 376 16.1.7.3 Recent developments 378 16.1.7.3.1 Product launches & approvals 378 16.1.7.3.2 Deals 378 16.1.7.3.3 Expansions 379 16.1.8 SARTORIUS AG 380 16.1.8.1 Business overview 380 16.1.8.2 Products offered 382 16.1.9 MERCK KGAA 383 16.1.9.1 Business overview 383 16.1.9.2 Products offered 385 16.1.9.3 Recent developments 385 16.1.9.3.1 Product launches & approvals 385 16.1.10 F. HOFFMANN-LA ROCHE LTD 386 16.1.10.1 Business overview 386 16.1.10.2 Products offered 387 16.1.10.3 Recent developments 388 16.1.10.3.1 Product launches & approvals 388 16.1.10.3.2 Deals 388 16.1.11 CHARLES RIVER LABORATORIES, INC. 389 16.1.11.1 Business overview 389 16.1.11.2 Products offered 390 16.1.11.3 Recent developments 391 16.1.11.3.1 Product launches 391 16.1.11.3.2 Deals 391 16.1.12 NEOGEN CORPORATION 392 16.1.12.1 Business overview 392 16.1.12.2 Products offered 393 16.1.12.3 Recent developments 394 16.1.12.3.1 Product launches 394 16.1.13 BIO-RAD LABORATORIES, INC. 395 16.1.13.1 Business overview 395 16.1.13.2 Products offered 396 16.1.13.3 Recent developments 397 16.1.13.3.1 Product launches & approvals 397 16.1.13.3.2 Deals 397 16.1.14 SHIMADZU CORPORATION 398 16.1.14.1 Business overview 398 16.1.14.2 Products offered 400 16.1.14.3 Recent developments 400 16.1.14.3.1 Expansions 400 16.1.15 RAPID MICRO BIOSYSTEMS, INC. 401 16.1.15.1 Business overview 401 16.1.15.2 Products offered 402 16.1.15.3 Recent developments 403 16.1.15.3.1 Deals 403 16.2 OTHER PLAYERS 404 16.2.1 DON WHITLEY SCIENTIFIC LIMITED 404 16.2.2 GRADIENTECH 405 16.2.3 RQMICRO AG 406 16.2.4 COLIFAST AS 407 16.2.5 HYGIENA LLC 408 16.2.6 COPAN DIAGNOSTICS INC. 409 16.2.7 PERKINELMER INC. 410 16.2.8 HARDY DIAGNOSTICS 411 16.2.9 CHARM SCIENCES 412 16.2.10 R-BIOPHARM 413 17 RESEARCH METHODOLOGY 414 17.1 RESEARCH DATA 414 17.2 RESEARCH APPROACH 414 17.2.1 SECONDARY RESEARCH 415 17.2.1.1 Key data from secondary sources 416 17.2.2 PRIMARY DATA 417 17.2.2.1 Primary sources 417 17.2.2.2 Key data from primary sources 418 17.2.2.3 Key industry insights 419 17.3 MARKET SIZE ESTIMATION 420 17.3.1 BOTTOM-UP APPROACH 421 17.3.1.1 Approach 1: Company revenue estimation approach 421 17.3.1.2 Approach 2: Presentations of companies and primary interviews 422 17.3.1.3 Growth forecast 422 17.3.2 TOP-DOWN APPROACH 423 17.4 MARKET BREAKDOWN AND DATA TRIANGULATION 424   17.5 MARKET SHARE ANALYSIS 425 17.6 RESEARCH ASSUMPTIONS 425 17.6.1 PARAMETRIC ASSUMPTIONS 425 17.6.2 GROWTH RATE ASSUMPTIONS 426 17.7 RESEARCH LIMITATIONS 426 17.8 RISK ASSESSMENT 426 18 APPENDIX 427 18.1 DISCUSSION GUIDE 427 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 432 18.3 CUSTOMIZATION OPTIONS 434 18.4 RELATED REPORTS 434 18.5 AUTHOR DETAILS 435
圖表清單 List of Tables & Figures
TABLE 1 ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE) 55 TABLE 2 TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024 55 TABLE 3 US: FOOD RECALLS AND REASONS, 2025 56 TABLE 4 US: FOOD RECALLS, BY SPECIES, 2025 57 TABLE 5 RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 67 TABLE 6 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030 68 TABLE 7 NORTH AMERICA: MACROECONOMIC INDICATORS 69 TABLE 8 EUROPE: MACROECONOMIC INDICATORS 70 TABLE 9 ASIA PACIFIC: MACROECONOMIC INDICATORS 70 TABLE 10 LATIN AMERICA: MACROECONOMIC INDICATORS 70 TABLE 11 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 71 TABLE 12 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2024–2026 (USD) 76 TABLE 13 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024–2026 (USD) 77 TABLE 14 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 78 TABLE 15 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 78 TABLE 16 RAPID MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 79 TABLE 17 US-ADJUSTED RECIPROCAL TARIFF RATES 83 TABLE 18 LIST OF MAJOR PATENTS PERTAINING TO RAPID MICROBIOLOGY TESTING MARKET, 2023–2025 89 TABLE 19 KEY COMPANIES IMPLEMENTING AI IN RAPID MICROBIOLOGY TESTING MARKET 92 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 25 GLOBAL STANDARDS IN THE RAPID MICROBIOLOGY TESTING MARKET 96 TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 100 TABLE 27 KEY BUYING CRITERIA, BY PRODUCT 100 TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES 101 TABLE 29 RAPID MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 102 TABLE 30 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 107 TABLE 31 KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET 108 TABLE 32 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 109 TABLE 33 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 109 TABLE 34 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 35 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 36 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 37 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 38 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112 TABLE 39 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 113 TABLE 40 NORTH AMERICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 41 EUROPE: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 42 ASIA PACIFIC: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 43 LATIN AMERICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 44 MIDDLE EAST & AFRICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 45 MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 116 TABLE 46 NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116 TABLE 47 EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 48 ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 49 LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 50 MIDDLE EAST & AFRICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 51 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 119 TABLE 52 NORTH AMERICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 53 EUROPE: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 54 ASIA PACIFIC: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 55 LATIN AMERICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 56 MIDDLE EAST & AFRICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 57 PCR SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 122 TABLE 58 NORTH AMERICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 59 EUROPE: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 60 ASIA PACIFIC: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 61 LATIN AMERICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 62 MIDDLE EAST & AFRICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 63 CYTOMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 125 TABLE 64 NORTH AMERICA: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 65 EUROPE: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 66 ASIA PACIFIC: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 67 LATIN AMERICA: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 68 MIDDLE EAST & AFRICA: CYTOMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 69 ACTIVE AIR SAMPLERS MARKET, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 70 NORTH AMERICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 71 EUROPE: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 72 ASIA PACIFIC: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 73 LATIN AMERICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 74 MIDDLE EAST & AFRICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 75 OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 76 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 77 EUROPE: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 78 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 79 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 80 MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 81 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 82 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 83 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 84 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 85 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 86 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 87 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 88 STERILITY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 89 NORTH AMERICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 90 EUROPE: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 91 ASIA PACIFIC: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 92 LATIN AMERICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 93 MIDDLE EAST & AFRICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 94 OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 95 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 96 EUROPE: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 97 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 98 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 99 MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 100 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 101 NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 102 EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 103 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 104 LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 105 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 106 GLOBAL: MALDI-TOF MS MICROBIAL IDENTIFICATION SYSTEM INSTALLED BASE VOLUME, 2024–2031 (UNITS) 146 TABLE 107 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 148 TABLE 108 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS 148 TABLE 109 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 110 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 111 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 112 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 113 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 114 MIDDLE EAST & AFRICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 115 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 116 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 117 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 118 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 119 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 120 MIDDLE EAST & AFRICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 121 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 122 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 123 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 124 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 125 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 126 MIDDLE EAST & AFRICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 127 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 128 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 129 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 130 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 131 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 132 MIDDLE EAST & AFRICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 133 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 134 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 135 EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 136 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 137 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 138 MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 139 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 166 TABLE 140 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 167 TABLE 141 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 142 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 143 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 144 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 145 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 146 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 147 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 148 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 149 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 150 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 151 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 152 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 153 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 154 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 155 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 156 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 157 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 158 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 159 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 160 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 161 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 162 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 163 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 164 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 165 QUALITY REGULATIONS & STANDARDS FOR COSMETICS & PERSONAL CARE 181 TABLE 166 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 167 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 168 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 169 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 170 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 171 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 172 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 173 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 174 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 175 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 176 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 177 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 178 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 179 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 180 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 181 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 182 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 183 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 184 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 185 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 186 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 187 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 188 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 189 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 190 RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 196 TABLE 191 RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, & ASCS, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 192 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 193 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 194 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 195 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 196 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 197 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 198 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 199 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 200 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 201 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 202 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 203 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 204 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 205 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 206 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 207 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 208 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 209 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 210 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 211 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 212 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 213 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 214 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 215 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 211 TABLE 216 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 217 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 218 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 219 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 220 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 221 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 222 NORTH AMERICA: MACROECONOMIC INDICATORS 217 TABLE 223 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 224 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 218 TABLE 225 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 226 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 227 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 220 TABLE 228 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 220 TABLE 229 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 230 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 221 TABLE 231 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 222 TABLE 232 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 233 US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 234 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 224 TABLE 235 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 224 TABLE 236 US: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 237 US: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 225 TABLE 238 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 226 TABLE 239 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 240 CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 241 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 228 TABLE 242 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 228 TABLE 243 CANADA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 244 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 229 TABLE 245 EUROPE: MACROECONOMIC INDICATORS 231 TABLE 246 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 247 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 231 TABLE 248 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 249 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 250 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 233 TABLE 251 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 233 TABLE 252 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 253 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 234 TABLE 254 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 235 TABLE 255 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 256 GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 257 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 237 TABLE 258 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 237 TABLE 259 GERMANY: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 260 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 238 TABLE 261 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 239 TABLE 262 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 263 FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 264 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 241 TABLE 265 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 241 TABLE 266 FRANCE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 267 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 242 TABLE 268 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 244 TABLE 269 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 270 UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 271 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 245 TABLE 272 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 245 TABLE 273 UK: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 274 UK: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 246 TABLE 275 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 247 TABLE 276 ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 277 ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 278 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 249 TABLE 279 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 249 TABLE 280 ITALY: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 281 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 250 TABLE 282 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 251 TABLE 283 SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 284 SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 285 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 253 TABLE 286 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 253 TABLE 287 SPAIN: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 288 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 254 TABLE 289 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 255 TABLE 290 RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 291 RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 292 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 257 TABLE 293 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 257 TABLE 294 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 295 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 258 TABLE 296 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 259 TABLE 297 REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 298 REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 299 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 261 TABLE 300 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 261 TABLE 301 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 302 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 262 TABLE 303 ASIA PACIFIC: MACROECONOMIC INDICATORS 263 TABLE 304 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 305 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 265 TABLE 306 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 307 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 308 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 266 TABLE 309 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 266 TABLE 310 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 311 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 267 TABLE 312 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 268 TABLE 313 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 314 CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 315 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 270 TABLE 316 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 270 TABLE 317 CHINA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 318 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 271 TABLE 319 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 273 TABLE 320 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 321 JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 322 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 274 TABLE 323 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 274 TABLE 324 JAPAN: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 325 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 275 TABLE 326 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 277 TABLE 327 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 328 INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 329 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 278 TABLE 330 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 278 TABLE 331 INDIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 332 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 279 TABLE 333 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 280 TABLE 334 SOUTH KOREA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 335 SOUTH KOREA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 336 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 282 TABLE 337 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 282 TABLE 338 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 339 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 283 TABLE 340 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 284 TABLE 341 AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 342 AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 343 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 286 TABLE 344 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 286 TABLE 345 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 346 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 287 TABLE 347 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 288 TABLE 348 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 349 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 350 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 290 TABLE 351 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 290 TABLE 352 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 353 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 291 TABLE 354 LATIN AMERICA: MACROECONOMIC INDICATORS 292 TABLE 355 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 356 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 293 TABLE 357 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 358 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 359 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 295 TABLE 360 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 295 TABLE 361 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 362 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 296 TABLE 363 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 297 TABLE 364 BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 365 BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 366 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 299 TABLE 367 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 299 TABLE 368 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 369 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 300 TABLE 370 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 301 TABLE 371 MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 372 MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 373 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 303 TABLE 374 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 303 TABLE 375 MEXICO: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 376 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 304 TABLE 377 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 305 TABLE 378 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 379 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 380 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 307 TABLE 381 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 307 TABLE 382 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 383 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 308 TABLE 384 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 310 TABLE 385 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 386 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 311 TABLE 387 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 388 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 389 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 312 TABLE 390 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 312 TABLE 391 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 392 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 313 TABLE 393 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 314 TABLE 394 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 395 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 396 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 316 TABLE 397 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 316 TABLE 398 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 399 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 317 TABLE 400 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 318 TABLE 401 UAE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 402 UAE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 403 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 320 TABLE 404 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 320 TABLE 405 UAE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 406 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 321 TABLE 407 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 322 TABLE 408 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 409 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 410 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024–2031 (USD MILLION) 324 TABLE 411 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 324 TABLE 412 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 413 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 325 TABLE 414 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN RAPID MICROBIOLOGY TESTING MARKET, JANUARY 2023−JUNE 2026 326 TABLE 415 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION 329 TABLE 416 RAPID MICROBIOLOGY TESTING MARKET: REGION FOOTPRINT 334 TABLE 417 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT 335 TABLE 418 RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT 335 TABLE 419 RAPID MICROBIOLOGY TESTING MARKET: END-USER FOOTPRINT 336 TABLE 420 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 338 TABLE 421 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 339 TABLE 422 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 339 TABLE 423 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 341 TABLE 424 RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2023–JUNE 2026 342 TABLE 425 RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026 343 TABLE 426 BIOMÉRIEUX: COMPANY OVERVIEW 344 TABLE 427 BIOMÉRIEUX: PRODUCTS OFFERED 346 TABLE 428 BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 348 TABLE 429 BIOMÉRIEUX: DEALS, JANUARY 2023–JUNE 2026 349 TABLE 430 BIOMÉRIEUX: OTHER DEVELOPMENTS, JANUARY 2023–JUNE 2026 350 TABLE 431 WATERS CORPORATION: COMPANY OVERVIEW 352 TABLE 432 WATERS CORPORATION: PRODUCTS OFFERED 354 TABLE 433 WATERS CORPORATION: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026 355 TABLE 434 WATERS CORPORATION: DEALS, JANUARY 2023–JUNE 2026 355 TABLE 435 DANAHER CORPORATION: COMPANY OVERVIEW 357 TABLE 436 DANAHER CORPORATION: PRODUCTS OFFERED 358 TABLE 437 DANAHER CORPORATION: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026 360 TABLE 438 DANAHER CORPORATION: DEALS, JANUARY 2023–JUNE 2026 360 TABLE 439 ABBOTT LABORATORIES: COMPANY OVERVIEW 362 TABLE 440 ABBOTT LABORATORIES: PRODUCTS OFFERED 363 TABLE 441 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026 365 TABLE 442 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 366 TABLE 443 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 367 TABLE 444 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026 369 TABLE 445 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JUNE 2026 369 TABLE 446 BRUKER CORPORATION: COMPANY OVERVIEW 371 TABLE 447 BRUKER CORPORATION: PRODUCTS OFFERED 373 TABLE 448 BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 374 TABLE 449 BRUKER CORPORATION: DEALS, JANUARY 2023–JUNE 2026 374 TABLE 450 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 375 TABLE 451 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 376 TABLE 452 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 378 TABLE 453 QUIDELORTHO CORPORATION: DEALS, JANUARY 2023–JUNE 2026 378 TABLE 454 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2023–JUNE 2026 379 TABLE 455 SARTORIUS AG: COMPANY OVERVIEW 380 TABLE 456 SARTORIUS AG: PRODUCTS OFFERED 382 TABLE 457 MERCK KGAA: COMPANY OVERVIEW 383 TABLE 458 MERCK KGAA: PRODUCTS OFFERED 385 TABLE 459 MERCK KGAA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 385 TABLE 460 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 386 TABLE 461 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 387 TABLE 462 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 388 TABLE 463 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2023–JUNE 2026 388 TABLE 464 CHARLES RIVER LABORATORIES, INC.: COMPANY OVERVIEW 389 TABLE 465 CHARLES RIVER LABORATORIES, INC.: PRODUCTS OFFERED 390 TABLE 466 CHARLES RIVER LABORATORIES, INC.: PRODUCT LAUNCHES 391 TABLE 467 CHARLES RIVER LABORATORIES, INC.: DEALS 391 TABLE 468 NEOGEN CORPORATION: COMPANY OVERVIEW 392 TABLE 469 NEOGEN CORPORATION: PRODUCTS OFFERED 393 TABLE 470 NEOGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026 394 TABLE 471 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 395 TABLE 472 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 396 TABLE 473 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 397 TABLE 474 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–JUNE 2026 397 TABLE 475 SHIMADZU CORPORATION: COMPANY OVERVIEW 398 TABLE 476 SHIMADZU CORPORATION: PRODUCTS OFFERED 400 TABLE 477 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2023–JUNE 2026 400 TABLE 478 RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW 401 TABLE 479 RAPID MICRO BIOSYSTEMS, INC: PRODUCTS OFFERED 402 TABLE 480 RAPID MICRO BIOSYSTEMS, INC.: DEALS, JANUARY 2023–JUNE 2026 403 TABLE 481 DON WHITLEY SCIENTIFIC LIMITED: COMPANY OVERVIEW 404 TABLE 482 GRADIENTECH: COMPANY OVERVIEW 405 TABLE 483 RQMICRO AG: COMPANY OVERVIEW 406 TABLE 484 COLIFAST AS: COMPANY OVERVIEW 407 TABLE 485 HYGIENA LLC: COMPANY OVERVIEW 408 TABLE 486 COPAN DIAGNOSTICS INC.: COMPANY OVERVIEW 409 TABLE 487 PERKINELMER INC.: COMPANY OVERVIEW 410 TABLE 488 HARDY DIAGNOSTICS: COMPANY OVERVIEW 411 TABLE 489 CHARM SCIENCES: COMPANY OVERVIEW 412 TABLE 490 R-BIOPHARM: COMPANY OVERVIEW 413 TABLE 491 RAPID MICROBIOLOGY TESTING MARKET: RISK ASSESSMENT 426 FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION 40 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 44 FIGURE 3 GLOBAL RAPID MICROBIOLOGY TESTING MARKET, 2024–2031 45 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET, 2023–2025 45 FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF RAPID MICROBIOLOGY TESTING MARKET 46 FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN RAPID MICROBIOLOGY TESTING MARKET, 2026–2031 47 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 48 FIGURE 8 INCREASING DEMAND FOR RAPID STERILITY TESTING, BIOBURDEN TESTING, AND ENVIRONMENTAL MONITORING TO DRIVE MARKET 49 FIGURE 9 REAGENTS & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 50 FIGURE 10 GROWTH-BASED SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 50 FIGURE 11 INDUSTRIAL TESTING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 51 FIGURE 12 HOSPITALS, CLINICAL LABORATORIES, AND ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 51 FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 52 FIGURE 14 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 FIGURE 15 RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 66 FIGURE 16 RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS 72 FIGURE 17 RAPID MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS 73 FIGURE 18 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS 74 FIGURE 19 RAPID MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80 FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN RAPID MICROBIOLOGY TESTING MARKET 80 FIGURE 21 PATENT ANALYSIS FOR RAPID MICROBIOLOGY TESTING, JANUARY 2015–DECEMBER 2025 88 FIGURE 22 MARKET POTENTIAL OF AI IN RAPID MICROBIOLOGY TESTING MARKET 91 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 99 FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT 100 FIGURE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT 217 FIGURE 26 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT 264 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET, 2023–2025 (USD MILLION) 328 FIGURE 28 RAPID MICROBIOLOGY TESTING MARKET SHARE ANALYSIS, 2025 (GLOBAL) 329 FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 332 FIGURE 30 RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT 333 FIGURE 31 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 337 FIGURE 32 EV/EBITDA OF KEY VENDORS 340 FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 340 FIGURE 34 RAPID MICROBIOLOGY TESTING MARKET: BRAND/PRODUCT COMPARISON FOR MALDI-TOF INSTRUMENT 341 FIGURE 35 BIOMÉRIEUX: COMPANY SNAPSHOT (2025) 345 FIGURE 36 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 353 FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 358 FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2025) 363 FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 367 FIGURE 40 BRUKER CORPORATION: COMPANY SNAPSHOT (2025) 372 FIGURE 41 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025) 376 FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2025) 381 FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2025) 384 FIGURE 44 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2025) 387 FIGURE 45 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 390 FIGURE 46 NEOGEN CORPORATION: COMPANY SNAPSHOT (2025) 393 FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 396 FIGURE 48 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025) 399 FIGURE 49 RAPID MICRO BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2025) 402 FIGURE 50 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY 414 FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 420 FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 420 FIGURE 53 GLOBAL RAPID MICROBIOLOGY TESTING MARKET: REVENUE SHARE ANALYSIS 421 FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 422 FIGURE 55 TOP-DOWN APPROACH 423 FIGURE 56 DATA TRIANGULATION METHODOLOGY 424

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們